6-Aziridin-1-yl-2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazole-5,8-dione

ID: ALA137209

PubChem CID: 10799416

Max Phase: Preclinical

Molecular Formula: C12H11N3O2

Molecular Weight: 229.24

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1C(N2CC2)=CC(=O)c2c1nc1n2CCC1

Standard InChI:  InChI=1S/C12H11N3O2/c16-8-6-7(14-4-5-14)12(17)10-11(8)15-3-1-2-9(15)13-10/h6H,1-5H2

Standard InChI Key:  OVRWFVWAYRXCKI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 17 20  0  0  0  0  0  0  0  0999 V2000
    7.3723   -3.6839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3723   -4.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0866   -4.9256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0866   -3.2669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8054   -3.6839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8099   -4.5096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5893   -3.4244    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0784   -4.0897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6014   -4.7613    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0928   -5.4224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8734   -5.1595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8644   -4.3358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0853   -2.4421    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0858   -5.7503    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6570   -3.2732    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2412   -2.5604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8306   -3.2757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  8  9  1  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  5  6  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  8  1  0
  1  2  2  0
  4 13  2  0
  1  4  1  0
  3 14  2  0
  6  9  1  0
  1 15  1  0
 16 15  1  0
 17 16  1  0
 15 17  1  0
  8  7  2  0
  7  5  1  0
M  END

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 229.24Molecular Weight (Monoisotopic): 229.0851AlogP: 0.41#Rotatable Bonds: 1
Polar Surface Area: 54.97Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.25CX LogP: -0.26CX LogD: -0.26
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.65Np Likeness Score: -0.35

References

1. Zhou R, Skibo EB..  (1996)  Chemistry of the pyrrolo[1,2-alpha]benzimidazole antitumor agents: influence of the 7-substituent on the ability to alkylate DNA and inhibit topoisomerase II.,  39  (21): [PMID:8863809] [10.1021/jm960064d]
2. Fahey K, O'Donovan L, Carr M, Carty MP, Aldabbagh F..  (2010)  The influence of the aziridinyl substituent of benzimidazoles and benzimidazolequinones on toxicity towards normal and Fanconi anaemia cells.,  45  (5): [PMID:20122765] [10.1016/j.ejmech.2010.01.026]

Source